{"id":"W2099712757","doi":"10.1093/annonc/mdr063","title":"Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179)","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"ca_institutions":"Queen's University; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Juravinski Cancer Centre","funders":"","keywords":"Temsirolimus; Carboplatin; Medicine; Tolerability; Paclitaxel; Adverse effect; Neutropenia; Nausea; Chemotherapy; Internal medicine; Toxicity; Common Terminology Criteria for Adverse Events; Pharmacology; Oncology; Urology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001148645,0.001526792,0.002556902,0.0007259111,0.0003668147,0.0007683702,0.0009154149,0.0008648394,0.002631403],"category_scores_gemma":[0.000788421,0.0005979671,0.001476381,0.0008365147,0.0008331863,0.001139524,0.0003311113,0.003678268,0.0007218878],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000828216,"about_ca_system_score_gemma":0.001495506,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001198351,"about_ca_topic_score_gemma":0.004323849,"domain_scores_codex":[0.9996302,0.0001717669,0.00002113134,0.00006127854,0.00004381068,0.00007177188],"domain_scores_gemma":[0.9995294,0.00008168328,0.00009358186,0.0000394761,0.00002216534,0.0002337659],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7359763,0.05648779,0.008984998,0.0009998041,0.002509184,0.0002261061,0.0003867898,0.003932951,0.03959766,0.0003610552,0.007723287,0.1428141],"study_design_scores_gemma":[0.6637471,0.3044351,0.0227229,0.00003661946,0.0007453628,0.0002693287,0.00008099008,0.001920459,0.00306055,0.0002112762,0.002725299,0.00004508912],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945145,0.001440663,0.0002901543,0.0004767195,0.00009889324,0.0007015747,0.0008553938,0.0001233866,0.001498783],"genre_scores_gemma":[0.9881122,0.002418167,0.001793687,0.0008429798,0.0002390968,0.00101623,0.002348695,0.0000557799,0.003173152],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002631403,"threshold_uncertainty_score":0.008802891,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1238114440220481,"score_gpt":0.438953404819226,"score_spread":0.3151419607971779,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}